Goodwin Procter and Carey Olsen advised Bregal Sagemount on the deal. Bregal Sagemount announced the formation of Bregal Sagemount Fund IV, which hit its hard cap...
Bregal Sagemount’s Formation of Bregal Sagemount Fund IV
Accordion’s Acquisition of ABACI
Goodwin Procter advised ABACI on the deal. Accordion, a private equity-focused financial and technology consulting firm, announced that it has acquired ABACI, an Enterprise Resourcing Planning...
Hoxton Farms’ $22 Million Series A Financing
Goodwin Procter advised Hoxton Farms on the deal. Hoxton Farms announced its $22 million Series A financing. The funding round was led by Collaborative Fund and...
Sensat’s $20.5 Million Series B Financing
Goodwin Procter advised Sensat on the deal. Sensat announced its $20.5 million Series B financing. The funding round was led by National Grid Partners, the corporate venture...
Goodwin welcomes public M&A Partner Kirkie Maswoswe in New York
Global law firm Goodwin announced that Kirkie Maswoswe joined the firm’s Mergers & Acquisitions practice and Technology group as a partner, resident in the New York...
Carlyle’s €500 Million Acquisition of Grupo Garnica Plywood
Cuatrecasas advised Grupo Garnica Plywood, while Gibson Dunn & Crutcher, Latham & Watkins and Pérez-Llorca advised The Carlyle Group. Allen & Overy has advised Intermediate Capital...
Mirova’s €100 Minority Stake Acquisition in Zunder
Cuatrecasas advised Mirova on the deal. Mirova Energy Transition 5 (Mirova), a subsidiary of Natixis Investment, acquired a €100 minority stake through a capital increase in Zunder,...
Tendam Group’s €605 Million Loan Refinancing
Cuatrecasas has advised a group of banks formed by Société Générale, ICO, Crédit Agricole, BBVA, CaixaBank, Intesa Sanpaolo, BNP Paribas, BNP Paribas Fortis, Deutsche Bank and...
DICE Therapeutics’ $345 Million Public Offering
Wilson Sonsini Goodrich & Rosati advised DICE Therapeutics on the deal. DICE Therapeutics, Inc., a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline...
Zymeworks’ Exclusive Licensing Agreement with Jazz Pharmaceuticals
Wilson Sonsini advised Zymeworks on the deal. Zymeworks BC Inc. and Jazz Pharmaceuticals Ireland Ltd. announced that they entered into an exclusive license agreement to develop...
Matter YS Biopharma’s Merger with Summit Healthcare Acquisition Corp.
Wilson Sonsini represented YS Biopharma on the deal. YishengBio Co., Ltd (YS Biopharma), a commercialization-stage biopharmaceutical company focusing on innovative vaccines and therapeutic biologics, and Summit...
Prize’s Business Combination with Rose Hill Acquisition Corporation
Paul Hastings LLP and Cariola, Díez, Pérez-Cotapos advised Prize on the deal. Greenberg Traurig and EY Law – Chile advised Rose Hill Acquisition Corp. Rose Hill...